Violetta Cotreau Akebia Therapeutics, Inc. (AKBA) insider trading activity

AKBA Quotes by TradingView

Violetta Cotreau is SVP, Chief Accounting Officer of Akebia Therapeutics, Inc.. Currently has a direct ownership of 219,954 shares of AKBA, which is worth approximately $365,123. The most recent transaction as insider was on May 12, 2022, when has been sold 150,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 220K
0% 3M change
0% 12M change
Total Value Held $365,123

Violetta Cotreau Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 12 2022
BUY
Grant, award, or other acquisition
-
150,000 Added 40.55%
219,954 Common Stock
Feb 28 2022
SELL
Open market or private sale
$8,484 $2.15 p/Share
3,946 Reduced 11.93%
29,121 Common Stock
Feb 28 2022
BUY
Grant, award, or other acquisition
-
40,833 Added 36.86%
69,954 Common Stock
Jan 03 2022
SELL
Open market or private sale
$13,358 $2.29 p/Share
5,833 Reduced 14.99%
33,067 Common Stock
Feb 26 2021
BUY
Grant, award, or other acquisition
-
26,000 Added 40.06%
38,900 Common Stock
VC

Violetta Cotreau

SVP, Chief Accounting Officer
Cambridge, MA

Track Institutional and Insider Activities on AKBA

Follow Akebia Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKBA shares.

Notify only if

Insider Trading

Get notified when an Akebia Therapeutics, Inc. insider buys or sells AKBA shares.

Notify only if

News

Receive news related to Akebia Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AKBA